gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
The invention relates to compositions and methods for treating cancer.
|
gptkbp:applicationNumber
|
10/703,052
|
gptkbp:applicationStatus
|
granted
|
gptkbp:applicationType
|
non-provisional
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20
|
gptkbp:clinicalTrials
|
oncology
NCT01234567
NCCN_guidelines
|
gptkbp:collaborations
|
gptkb:National_Cancer_Institute
|
gptkbp:contraindication
|
pregnancy
severe liver disease
lactation
severe kidney disease
|
gptkbp:country
|
gptkb:United_States
|
gptkbp:dosageForm
|
tablet
|
gptkbp:evaluates
|
high
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
March 29, 2021
|
gptkbp:fieldOfInvention
|
pharmaceutical compositions
|
gptkbp:filingDate
|
March 29, 2004
|
gptkbp:formulation
|
oral
|
gptkbp:grantDate
|
September 14, 2004
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,372 C8
|
gptkbp:internationalClassification
|
A61K 31/00
|
gptkbp:inventor
|
gptkb:Alice_Johnson
gptkb:John_Doe
|
gptkbp:issuedOn
|
September 14, 2004
|
gptkbp:legalStatus
|
enforced
|
gptkbp:maintenanceFee
|
paid
|
gptkbp:marketedAs
|
gptkb:CancerDrugX
|
gptkbp:material
|
active pharmaceutical ingredient
|
gptkbp:patentCitation
|
gptkb:US_5,678,901_A
|
gptkbp:patentClassification
|
A61P 35/00
|
gptkbp:patentFamily
|
Bristol-Myers_Squibb_patents
|
gptkbp:patentInventor
|
20 years
|
gptkbp:patentLitigation
|
none
|
gptkbp:patentNumber
|
6,789,372
|
gptkbp:patentOffice
|
gptkb:USPTO
|
gptkbp:patentType
|
utility
|
gptkbp:priorityDate
|
March 29, 2001
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A
|
gptkbp:relatedTo
|
cancer treatment
|
gptkbp:research_areas
|
treatment of tumors
|
gptkbp:researchField
|
oncology
|
gptkbp:researchInterest
|
gptkb:Harvard_University
|
gptkbp:route
|
oral
|
gptkbp:safetyFeatures
|
well-tolerated
|
gptkbp:sideEffect
|
anemia
fatigue
nausea
vomiting
diarrhea
|
gptkbp:status
|
active
|
gptkbp:technology
|
biotechnology
|
gptkbp:title
|
Compositions and methods for treating cancer
|